CD8A and non-small cell lung carcinoma: As is mentioned above, circ-CPA4 can regulate cell growth, mobility, stemness and drug resistance in NSCLC cells and inactivates CD8+ T cells in the tumor immune microenvironment through the let-7 miRNA/PD-L1 axis.